Analyst Price Targets — MDLN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 3, 2026 10:39 am | Eric Coldwell | Robert W. Baird | $45.00 | $33.19 | TheFly | Medline price target lowered to $45 from $57 at Baird |
| June 1, 2026 10:05 am | Glen Santangelo | Barclays | $45.00 | $36.56 | TheFly | Medline price target lowered to $45 from $50 at Barclays |
| May 7, 2026 12:41 pm | — | Deutsche Bank | $42.00 | $41.95 | TheFly | Medline price target lowered to $42 from $48 at Deutsche Bank |
| March 9, 2026 12:03 pm | Ivan Feinseth | Tigress Financial | $60.00 | $43.41 | TheFly | Medline price target raised to $60 from $55 at Tigress Financial |
| February 25, 2026 7:48 pm | Michael Cherny | Leerink Partners | $56.00 | $48.18 | TheFly | Medline price target raised to $56 from $48 at Leerink |
| February 25, 2026 7:45 pm | — | Stifel Nicolaus | $55.00 | $48.18 | TheFly | Medline price target raised to $55 from $46 at Stifel |
| February 25, 2026 6:37 pm | — | Evercore ISI | $55.00 | $49.38 | TheFly | Medline price target raised to $55 from $50 at Evercore ISI |
| February 5, 2026 2:47 pm | — | Tigress Financial | $55.00 | $45.01 | TheFly | Medline initiated with a Buy at Tigress Financial |
| January 21, 2026 12:16 pm | David Larsen | J.P. Morgan | $55.00 | $43.17 | TheFly | Medline price target raised to $55 from $50 at BTIG |
| January 12, 2026 1:39 pm | — | Barclays | $50.00 | $41.65 | TheFly | Medline initiated with an Overweight at Barclays |
Latest News for MDLN
Cutting-edge distribution center to reinforce Medline's supply chain resilience in California NORTHFIELD, Ill., July 20, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has announced plans to open a new distribution center in Perris, Calif.
New York, New York--(Newsfile Corp. - July 20, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to…
New York, New York--(Newsfile Corp. - July 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to…
NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
SAN FRANCISCO, July 7, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MDLN.
U.S. House Trading
No House trades found for MDLN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.